• Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us
Skip to content
Skip to content
logo
  • Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us

August 4, 2026

  • Home
  • 2026
  • August
  • 4
Strategy

Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing

August 4, 2026 Cirrus No comments yet

Cirrus deepens expansion into Singapore and the Asia-Pacific region through collaboration with Singapore Eye Research Institute and Duke-NUS Medical School’s Centre for Vision Research to support research, clinical development and partnering activities Cirrus expands investor syndicate with new additions, including Cedars Sinai Intellectual Property Company, raising $14.7 million to date Cirrus continues to advance its […]

Search

Categories

  • Strategy (13)

Recent posts

  • Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing
  • Cirrus Therapeutics Announces Strategic Expansion to Singapore and Other Key Updates Supporting its Growth as a Leading Global Ocular Immunology Company
  • Q&A: A Blavatnik Fellow’s Journey: Ying Kai Chan on Vision Science, Innovation, and Cirrus Therapeutics

Tags

Agenda Community Equality Initiative Social Strength

© 2025-2026 Cirrus Therapeutics. All rights reserved.

  • Privacy Policy
  • Terms of Service